Simplex Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Simplex Trading’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,771	Closed	-$6K	–	7186
2016 Q3	$6K	Sell	18,771 -26,500	-59%	-$8.47K	﹤0.01%	4213
2016 Q2	$21K	Buy	45,271 +38,369	+556%	+$17.8K	﹤0.01%	2874
2016 Q1	$9K	Buy	6,902 +1,710	+33%	+$2.23K	﹤0.01%	3642
2015 Q4	$7K	Buy	5,192 +4,000	+336%	+$5.39K	﹤0.01%	3685
2015 Q3	$1K	Buy	+1,192	New	+$1K	﹤0.01%	5387

Simplex Trading's RXII Position: Q4 2016 in Review

Simplex Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 18,771 shares — an estimated $6K sold.

Simplex Trading first reported a position in RXII in Q3 2015 and held it in 5 quarters. The position peaked at $21K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Simplex Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Simplex Trading sold 18,771 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $6K.
Simplex Trading first reported a position in GALENA BIOPHARMA INC COM in Q3 2015 and held it in 5 quarters.
Simplex Trading's GALENA BIOPHARMA INC COM position peaked at $21K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.